Endometrial Curettage When and for Who

Aslıhan Duman; Ferah Tuncel Daloğlu; Yeliz Arman Karakaya; Aysun Aras

doi:doi:10.11648/j.jctr.20150302.11

| Peer-Reviewed

Endometrial Curettage When and for Who

Aslıhan Duman, Ferah Tuncel Daloğlu, Yeliz Arman Karakaya, Aysun Aras

Published in Journal of Cancer Treatment and Research (Volume 3, Issue 2)

Received: 12 February 2015 Accepted: 27 February 2015 Published: 9 March 2015

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

In this study, the histopathological diagnoses pertaining to curettage material and the clinical necessity and results of endometrial curettagein age groups of patients in our region who had curettage due to abnormal uterine bleeding were studied. Thehistopathological diagnoses of patients with the above-mentioned criteria were scanned, excluding those related to pregnancy. 409 cases were re-examined and evaluated by a group consisting of three pathologists. Diagnoses were classified into 10 different groups. According to this classification system, out of the total number of cases, 100 were defined as endometrial polyp (24.4%), 72 cases as secretory endometrium (17.6%), 59 cases as proliferative endometrium (14.4%), 51 cases as stromal/glandular degeneration (12.5%), 32 cases as irregular proliferation (7.8%), 26 cases as insufficient (6.4%), 22 cases as chronic endometritis (5.6%), 18 cases as decidualization (4.4%), 17 cases as endometrial hyperplasia (complex atypical)/ adenocarcinoma (4.2%), and 12 cases as others (inactive, atrophic, basal and menstrual endometrium) (2.9%). The average age of the 409 cases was 44.8±7.8. Upon evaluation of curettage due to abnormal uterine bleeding in the approximate 3 year period in our region, and taking into consideration the age distribution, it was observed that the clinical pre-diagnoses of patients especially with endometrial polyps and precancerous lesions were coherent with the corresponding histopathological diagnoses.

Published in	Journal of Cancer Treatment and Research (Volume 3, Issue 2)
DOI	10.11648/j.jctr.20150302.11
Page(s)	17-21
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2015. Published by Science Publishing Group

Keywords

Endometrium, Curettage, Histopathological Diagnosis, Age

References

[1]	Doraiswami S., Johnson T., Rao S., Rajkumar A., Vijayaraghavan J., Panicker VK. Study of Endometrial Pathology in Abnormal Uterine Bleeding.J Obstet Gynaecol India. 2011; 61(4):426-30.
[2]	Lasmar BP., Lasmar RB. Endometrial polyp size and polyp hyperplasia.Int J Gynaecol Obstet. 2013 ;123(3):236-9
[3]	Çakmak B., Karataş A., TuranG. Endometrial Örnekleme Sonuçlarımız: 400 Olgunun Analizi.Selçuk Tıp Derg. 2012; 28(3):163-166
[4]	Goertzen J., Hutten-Czapski P. The occasional endometrial biopsy.Can J Rural Med. 2010; 15(3):113-7
[5]	Carvalho FM, Aguiar FN, Tomioka R, de Oliveira RM, Frantz N, Ueno J. Functional endometrial polyps in infertile asymptomatic patients: a possible evolution of vascular changes secondary to endometritis.Eur J Obstet Gynecol Reprod Biol. 2013; 170(1):152-6.
[6]	Sweet MG, Schmidt-Dalton TA, Weiss PM, Madsen KP. Evaluation and Management of Abnormal Uterine Bleeding in Premenopausal Women. Am Fam Physician. 2012 ; 85(1): 35-43.
[7]	Dascanio JJ, McCuePM, Endometrial Biopsy. John Wiley & Sons. Published Online: 27 JUN 2014 DOI: 10.1002/9781118904398.ch19
[8]	Saadia A, Mubarik A, Zubair A, Jamal S, Zafar A.Diagnostic accuracy of endometrial curettage in endometrial pathology.J Ayub Med Coll Abbottabad. 2011 ; 23(1):129-31.
[9]	Silverberg SG.The Endometrium Pathologic Principles and Pitfalls. Arch Pathol Lab Med. 2007; 131: 372-82
[10]	McCluggage WG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol. 2006 ;59(8):801-12
[11]	İvit H., Köksal A., Çukurova K., Keklik A., Yıldız A., Yetimalar H., Sapmaz L. Postmenopozal kanamalı olguların endobrush endometrial örnekleme yöntemiyle değerlendirilmesi. SSK İzmir Eğitim Hastanesi Tıp Dergisi. 2004, 10 (1): 15-19.
[12]	Endometrial hiperplazi tanısı verilen hastaların prognozlarının retrospektif olarak değerlendirilmesi Oğuz S., L. Gözeri L.İ., Akdoğan E.,K., Saraç G., Akyağcı A.
[13]	Blaustein's Pathology of the Female Genital Tract Kurman, Robert J., Hedrick Ellenson, Lora, Ronnett, Brigitte M. (Eds.)6th ed. 2011,page 305- 452.

Cite This Article

Plain Text BibTeX RIS

APA Style

Aslıhan Duman, Ferah Tuncel Daloğlu, Yeliz Arman Karakaya, Aysun Aras. (2015). Endometrial Curettage When and for Who. Journal of Cancer Treatment and Research, 3(2), 17-21. https://doi.org/10.11648/j.jctr.20150302.11

Copy | Download

ACS Style

Aslıhan Duman; Ferah Tuncel Daloğlu; Yeliz Arman Karakaya; Aysun Aras. Endometrial Curettage When and for Who. J. Cancer Treat. Res. 2015, 3(2), 17-21. doi: 10.11648/j.jctr.20150302.11

Copy | Download

AMA Style

Aslıhan Duman, Ferah Tuncel Daloğlu, Yeliz Arman Karakaya, Aysun Aras. Endometrial Curettage When and for Who. J Cancer Treat Res. 2015;3(2):17-21. doi: 10.11648/j.jctr.20150302.11

Copy | Download

@article{10.11648/j.jctr.20150302.11,
  author = {Aslıhan Duman and Ferah Tuncel Daloğlu and Yeliz Arman Karakaya and Aysun Aras},
  title = {Endometrial Curettage When and for Who},
  journal = {Journal of Cancer Treatment and Research},
  volume = {3},
  number = {2},
  pages = {17-21},
  doi = {10.11648/j.jctr.20150302.11},
  url = {https://doi.org/10.11648/j.jctr.20150302.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jctr.20150302.11},
  abstract = {In this study, the histopathological diagnoses pertaining to curettage material and the clinical necessity and results of endometrial curettagein age groups of patients in our region who had curettage due to abnormal uterine bleeding were studied. Thehistopathological diagnoses of patients with the above-mentioned criteria were scanned, excluding those related to pregnancy. 409 cases were re-examined and evaluated by a group consisting of three pathologists. Diagnoses were classified into 10 different groups. According to this classification system, out of the total number of cases, 100 were defined as endometrial polyp (24.4%), 72 cases as secretory endometrium (17.6%), 59 cases as proliferative endometrium (14.4%), 51 cases as stromal/glandular degeneration (12.5%), 32 cases as irregular proliferation (7.8%), 26 cases as insufficient (6.4%), 22 cases as chronic endometritis (5.6%), 18 cases as decidualization (4.4%), 17 cases as endometrial hyperplasia (complex atypical)/ adenocarcinoma (4.2%), and 12 cases as others (inactive, atrophic, basal and menstrual endometrium) (2.9%). The average age of the 409 cases was 44.8±7.8. Upon evaluation of curettage due to abnormal uterine bleeding in the approximate 3 year period in our region, and taking into consideration the age distribution, it was observed that the clinical pre-diagnoses of patients especially with endometrial polyps and precancerous lesions were coherent with the corresponding histopathological diagnoses.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - Endometrial Curettage When and for Who
AU  - Aslıhan Duman
AU  - Ferah Tuncel Daloğlu
AU  - Yeliz Arman Karakaya
AU  - Aysun Aras
Y1  - 2015/03/09
PY  - 2015
N1  - https://doi.org/10.11648/j.jctr.20150302.11
DO  - 10.11648/j.jctr.20150302.11
T2  - Journal of Cancer Treatment and Research
JF  - Journal of Cancer Treatment and Research
JO  - Journal of Cancer Treatment and Research
SP  - 17
EP  - 21
PB  - Science Publishing Group
SN  - 2376-7790
UR  - https://doi.org/10.11648/j.jctr.20150302.11
AB  - In this study, the histopathological diagnoses pertaining to curettage material and the clinical necessity and results of endometrial curettagein age groups of patients in our region who had curettage due to abnormal uterine bleeding were studied. Thehistopathological diagnoses of patients with the above-mentioned criteria were scanned, excluding those related to pregnancy. 409 cases were re-examined and evaluated by a group consisting of three pathologists. Diagnoses were classified into 10 different groups. According to this classification system, out of the total number of cases, 100 were defined as endometrial polyp (24.4%), 72 cases as secretory endometrium (17.6%), 59 cases as proliferative endometrium (14.4%), 51 cases as stromal/glandular degeneration (12.5%), 32 cases as irregular proliferation (7.8%), 26 cases as insufficient (6.4%), 22 cases as chronic endometritis (5.6%), 18 cases as decidualization (4.4%), 17 cases as endometrial hyperplasia (complex atypical)/ adenocarcinoma (4.2%), and 12 cases as others (inactive, atrophic, basal and menstrual endometrium) (2.9%). The average age of the 409 cases was 44.8±7.8. Upon evaluation of curettage due to abnormal uterine bleeding in the approximate 3 year period in our region, and taking into consideration the age distribution, it was observed that the clinical pre-diagnoses of patients especially with endometrial polyps and precancerous lesions were coherent with the corresponding histopathological diagnoses.
VL  - 3
IS  - 2
ER  -

Copy | Download

Author Information

Aslıhan Duman
Ferah Tuncel Daloğlu
Yeliz Arman Karakaya

Isparta State Hospital, Pathology Specialist, Isparta, Turkey
Aysun Aras

A?r? Public Health Directorate, Public Health Specialist, A?r?, Turkey

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Aslıhan Duman, Ferah Tuncel Daloğlu, Yeliz Arman Karakaya, Aysun Aras. (2015). Endometrial Curettage When and for Who. Journal of Cancer Treatment and Research, 3(2), 17-21. https://doi.org/10.11648/j.jctr.20150302.11

Copy | Download

ACS Style

Aslıhan Duman; Ferah Tuncel Daloğlu; Yeliz Arman Karakaya; Aysun Aras. Endometrial Curettage When and for Who. J. Cancer Treat. Res. 2015, 3(2), 17-21. doi: 10.11648/j.jctr.20150302.11

Copy | Download

AMA Style

Aslıhan Duman, Ferah Tuncel Daloğlu, Yeliz Arman Karakaya, Aysun Aras. Endometrial Curettage When and for Who. J Cancer Treat Res. 2015;3(2):17-21. doi: 10.11648/j.jctr.20150302.11

Copy | Download

@article{10.11648/j.jctr.20150302.11,
  author = {Aslıhan Duman and Ferah Tuncel Daloğlu and Yeliz Arman Karakaya and Aysun Aras},
  title = {Endometrial Curettage When and for Who},
  journal = {Journal of Cancer Treatment and Research},
  volume = {3},
  number = {2},
  pages = {17-21},
  doi = {10.11648/j.jctr.20150302.11},
  url = {https://doi.org/10.11648/j.jctr.20150302.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jctr.20150302.11},
  abstract = {In this study, the histopathological diagnoses pertaining to curettage material and the clinical necessity and results of endometrial curettagein age groups of patients in our region who had curettage due to abnormal uterine bleeding were studied. Thehistopathological diagnoses of patients with the above-mentioned criteria were scanned, excluding those related to pregnancy. 409 cases were re-examined and evaluated by a group consisting of three pathologists. Diagnoses were classified into 10 different groups. According to this classification system, out of the total number of cases, 100 were defined as endometrial polyp (24.4%), 72 cases as secretory endometrium (17.6%), 59 cases as proliferative endometrium (14.4%), 51 cases as stromal/glandular degeneration (12.5%), 32 cases as irregular proliferation (7.8%), 26 cases as insufficient (6.4%), 22 cases as chronic endometritis (5.6%), 18 cases as decidualization (4.4%), 17 cases as endometrial hyperplasia (complex atypical)/ adenocarcinoma (4.2%), and 12 cases as others (inactive, atrophic, basal and menstrual endometrium) (2.9%). The average age of the 409 cases was 44.8±7.8. Upon evaluation of curettage due to abnormal uterine bleeding in the approximate 3 year period in our region, and taking into consideration the age distribution, it was observed that the clinical pre-diagnoses of patients especially with endometrial polyps and precancerous lesions were coherent with the corresponding histopathological diagnoses.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - Endometrial Curettage When and for Who
AU  - Aslıhan Duman
AU  - Ferah Tuncel Daloğlu
AU  - Yeliz Arman Karakaya
AU  - Aysun Aras
Y1  - 2015/03/09
PY  - 2015
N1  - https://doi.org/10.11648/j.jctr.20150302.11
DO  - 10.11648/j.jctr.20150302.11
T2  - Journal of Cancer Treatment and Research
JF  - Journal of Cancer Treatment and Research
JO  - Journal of Cancer Treatment and Research
SP  - 17
EP  - 21
PB  - Science Publishing Group
SN  - 2376-7790
UR  - https://doi.org/10.11648/j.jctr.20150302.11
AB  - In this study, the histopathological diagnoses pertaining to curettage material and the clinical necessity and results of endometrial curettagein age groups of patients in our region who had curettage due to abnormal uterine bleeding were studied. Thehistopathological diagnoses of patients with the above-mentioned criteria were scanned, excluding those related to pregnancy. 409 cases were re-examined and evaluated by a group consisting of three pathologists. Diagnoses were classified into 10 different groups. According to this classification system, out of the total number of cases, 100 were defined as endometrial polyp (24.4%), 72 cases as secretory endometrium (17.6%), 59 cases as proliferative endometrium (14.4%), 51 cases as stromal/glandular degeneration (12.5%), 32 cases as irregular proliferation (7.8%), 26 cases as insufficient (6.4%), 22 cases as chronic endometritis (5.6%), 18 cases as decidualization (4.4%), 17 cases as endometrial hyperplasia (complex atypical)/ adenocarcinoma (4.2%), and 12 cases as others (inactive, atrophic, basal and menstrual endometrium) (2.9%). The average age of the 409 cases was 44.8±7.8. Upon evaluation of curettage due to abnormal uterine bleeding in the approximate 3 year period in our region, and taking into consideration the age distribution, it was observed that the clinical pre-diagnoses of patients especially with endometrial polyps and precancerous lesions were coherent with the corresponding histopathological diagnoses.
VL  - 3
IS  - 2
ER  -

Copy | Download